Advanced high-grade epithelial ovarian cancer

Clinical trials for Advanced high-grade epithelial ovarian cancer explained in plain language.

Never miss a new study

Get alerted when new Advanced high-grade epithelial ovarian cancer trials appear

Sign up with your email to follow new studies for Advanced high-grade epithelial ovarian cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

New cocktail aims to stall ovarian cancer

Disease control Ongoing

This Phase 3 trial tests whether adding durvalumab (an immunotherapy) and olaparib (a targeted drug) to standard chemotherapy and bevacizumab can help people with newly diagnosed advanced ovarian cancer live longer without their cancer growing. About 1,400 participants are involv…

Matched conditions: ADVANCED HIGH-GRADE EPITHELIAL OVARIAN CANCER

Phase 3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC

Advanced high-grade epithelial ovarian cancer

Get alerted when new Advanced high-grade epithelial ovarian cancer trials appear

New cocktail aims to stall ovarian cancer